We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

41 hedge funds and large institutions have $30.1M invested in Cumberland Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

33.88% more ownership

Funds ownership: 0% → 33.88% (+34%)

11% more capital invested

Capital invested by funds: $27.1M → $30.1M (+$3.02M)

3% more funds holding

Funds holding: 40 → 41 (+1)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
14
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$1.54M
2
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$69.9K
3
BIT
BlackRock Institutional Trust
California
+$61.6K
4
Renaissance Technologies
Renaissance Technologies
New York
+$51.6K
5
AA
Ancora Advisors
Ohio
+$18.8K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$1.17M
2
UCFA
United Capital Financial Advisors
Texas
-$139K
3
Morgan Stanley
Morgan Stanley
New York
-$65.1K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$38.1K
5
Invesco
Invesco
Georgia
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$10M -$1.17M -225,180 -11%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$4.69M +$14.6K +2,791 +0.3%
SCM
3
Stonepine Capital Management
Oregon
$3.41M +$1.54M +295,791 +91%
BIT
4
BlackRock Institutional Trust
California
$2.1M +$61.6K +11,802 +3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.64M -$3.48K -668 -0.2%
New York State Common Retirement Fund
6
New York State Common Retirement Fund
New York
$1.59M +$69.9K +13,400 +5%
BCM
7
Bridgeway Capital Management
Texas
$1.52M – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$1.41M +$51.6K +9,900 +4%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$692K -$38.1K -7,304 -5%
BA
10
Bard Associates
Illinois
$509K -$7.82K -1,500 -2%
Invesco
11
Invesco
Georgia
$405K -$13K -2,500 -3%
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$296K – – –
EGA
13
Eagle Global Advisors
Texas
$290K – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$266K +$1.65K +316 +0.7%
UCFA
15
United Capital Financial Advisors
Texas
$201K -$139K -26,679 -42%
BFA
16
BlackRock Fund Advisors
California
$182K +$7.11K +1,363 +4%
Northern Trust
17
Northern Trust
Illinois
$150K +$8.15K +1,562 +6%
SIM
18
Spark Investment Management
New York
$124K +$13.6K +2,600 +13%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$112K -$1.35K -258 -1%
Morgan Stanley
20
Morgan Stanley
New York
$103K -$65.1K -12,473 -40%
DAM
21
Delta Asset Management
Tennessee
$67K – – –
JAM
22
JW Asset Management
Florida
$61K – – –
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$58K -$4.69K -900 -8%
Cambridge Investment Research Advisors
24
Cambridge Investment Research Advisors
Iowa
$55K – – –
Russell Investments Group
25
Russell Investments Group
United Kingdom
$29K +$27.1K +5,198 New
1
2

CPIX Hedge Fund Activity: Q4 2016 in Review

41 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2016, worth a combined $30.1M — up 11% from $27.1M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPIX positions and 1 closed out — a net gain of 2 holders — while 12 added to existing stakes and 14 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $1.54M. The largest seller was Ariel Investments, cutting an estimated $1.17M.

  • 41 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2016, up from 40 in Q3 2016.
  • Funds reported $30.1M of Cumberland Pharmaceuticals stock for Q4 2016, up 11% quarter-over-quarter.
  • 3 funds opened new Cumberland Pharmaceuticals positions in Q4 2016 and 1 closed out, a net change of +2 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2016 was Stonepine Capital Management, an estimated $1.54M added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2016 was Ariel Investments, an estimated $1.17M sold.

Based on aggregated 13F filings for Q4 2016.